NCT07599241Recruiting
Additive Efficacy of Physical Activity Program in Hypthyroidism Elder Females With Glaucoma and Fatty Liver Issues
Source: ClinicalTrials.gov · Last updated 20 May 2026
Brief summary (registry, in English)
additive efficacy of physical activity program in hypthyroidism in elder females with glaucoma and fatty liver issues was not investigated
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 9 May 2026
- Start date
- 15 Mar 2026
- Primary completion date
- 15 Dec 2026
- Lead sponsor
- Cairo University
- Diseases
- Glaucoma, Fatty liver disease (MASLD/MASH)
- NCT number
- NCT07599241
What you commit to
- Study type: Interventional
- Planned participants: 40
- From 15 Mar 2026 to the primary completion date, 15 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- cardiac issues
Other
- respiratory issues
- renal issues
Who the study is looking for
- subclinical hypothrodism (significant form)
- primary opened angle gaulcoma in both eyes with ocular hypertension in both eyes )(high-tension typed glaucoma)
- fatty liver (non alcholic type)
- elder females
Age in the registry: 65 years to 75 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cairo University Coordinator of this site? Confirm its status | Dokki | Egypt | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.